Advertisement

Reactions Weekly

, Volume 1730, Issue 1, pp 5–5 | Cite as

US FDA warns that stopping Gilenya can worsen MS

News item
  • 19 Downloads

Reference

  1. US Food and Drug Administration. FDA warns about severe worsening of multiple sclerosis after stopping the medicine Gilenya (fingolimod). Internet Document : 20 Nov 2018. Available from: URL: https://www.fda.gov/Drugs/DrugSafety/ucm626095.htm

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations